These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8028615)

  • 1. A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I.
    Grompe M; St-Louis M; Demers SI; al-Dhalimy M; Leclerc B; Tanguay RM
    N Engl J Med; 1994 Aug; 331(6):353-7. PubMed ID: 8028615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of the IVS12 + 5G-->A splice mutation of the fumarylacetoacetate hydrolase gene in carriers of hereditary tyrosinaemia in the French Canadian population of Saguenay-Lac-St-Jean.
    Poudrier J; St-Louis M; Lettre F; Gibson K; Prévost C; Larochelle J; Tanguay RM
    Prenat Diagn; 1996 Jan; 16(1):59-64. PubMed ID: 8821854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I.
    Grompe M; al-Dhalimy M
    Hum Mutat; 1993; 2(2):85-93. PubMed ID: 8318997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility in couples heterozygous for the tyrosinemia gene in Saguenay Lac-St-Jean.
    De Braekeleer M; Lamarre V; Scriver CR; Larochelle J; Bouchard G
    Genet Couns; 1990; 1(3-4):259-64. PubMed ID: 2098050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary tyrosinemia type I: strong association with haplotype 6 in French Canadians permits simple carrier detection and prenatal diagnosis.
    Demers SI; Phaneuf D; Tanguay RM
    Am J Hum Genet; 1994 Aug; 55(2):327-33. PubMed ID: 7913582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosinemia: the Quebec experience.
    Paradis K
    Clin Invest Med; 1996 Oct; 19(5):311-6. PubMed ID: 8889268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of mutations in the fumarylacetoacetate hydrolase gene of tyrosinemia type 1 patients in northwestern Europe and Mediterranean countries.
    Bergman AJ; van den Berg IE; Brink W; Poll-The BT; Ploos van Amstel JK; Berger R
    Hum Mutat; 1998; 12(1):19-26. PubMed ID: 9633815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview.
    St-Louis M; Tanguay RM
    Hum Mutat; 1997; 9(4):291-9. PubMed ID: 9101289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid nonradioactive assay for the detection of the common French Canadian tyrosinemia type I mutation.
    Grompe M; al-Dhalimy M
    Hum Mutat; 1995; 5(1):105. PubMed ID: 7728147
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterozygosity for an exon 12 splicing mutation and a W234G missense mutation in an American child with chronic tyrosinemia type 1.
    Hahn SH; Krasnewich D; Brantly M; Kvittingen EA; Gahl WA
    Hum Mutat; 1995; 6(1):66-73. PubMed ID: 7550234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.
    Phaneuf D; Lambert M; Laframboise R; Mitchell G; Lettre F; Tanguay RM
    J Clin Invest; 1992 Oct; 90(4):1185-92. PubMed ID: 1401056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different clinical forms of hereditary tyrosinemia (type I) in patients with identical genotypes.
    Poudrier J; Lettre F; Scriver CR; Larochelle J; Tanguay RM
    Mol Genet Metab; 1998 Jun; 64(2):119-25. PubMed ID: 9705236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis mutations in French Canadians: three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosis.
    Rozen R; De Braekeleer M; Daigneault J; Ferreira-Rajabi L; Gerdes M; Lamoureux L; Aubin G; Simard F; Fujiwara TM; Morgan K
    Am J Med Genet; 1992 Feb; 42(3):360-4. PubMed ID: 1536179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six novel mutations in the fumarylacetoacetate hydrolase gene of patients with hereditary tyrosinemia type I.
    Timmers C; Grompe M
    Hum Mutat; 1996; 7(4):367-9. PubMed ID: 8723690
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I.
    St-Louis M; Leclerc B; Laine J; Salo MK; Holmberg C; Tanguay RM
    Hum Mol Genet; 1994 Jan; 3(1):69-72. PubMed ID: 8162054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing mutations, mainly IVS6-1(G>T), account for 70% of fumarylacetoacetate hydrolase (FAH) gene alterations, including 7 novel mutations, in a survey of 29 tyrosinemia type I patients.
    Arranz JA; Piñol F; Kozak L; Pérez-Cerdá C; Cormand B; Ugarte M; Riudor E
    Hum Mutat; 2002 Sep; 20(3):180-8. PubMed ID: 12203990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic epidemiology of hereditary tyrosinemia in Quebec and in Saguenay-Lac-St-Jean.
    De Braekeleer M; Larochelle J
    Am J Hum Genet; 1990 Aug; 47(2):302-7. PubMed ID: 2378355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship.
    Ploos van Amstel JK; Bergman AJ; van Beurden EA; Roijers JF; Peelen T; van den Berg IE; Poll-The BT; Kvittingen EA; Berger R
    Hum Genet; 1996 Jan; 97(1):51-9. PubMed ID: 8557261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria.
    Tomoeda K; Awata H; Matsuura T; Matsuda I; Ploechl E; Milovac T; Boneh A; Scott CR; Danks DM; Endo F
    Mol Genet Metab; 2000 Nov; 71(3):506-10. PubMed ID: 11073718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal recessive disorders in Saguenay-Lac-St-Jean, Quebec: study of kinship.
    De Braekeleer M; Gauthier S
    Hum Biol; 1996 Jun; 68(3):371-81. PubMed ID: 8935318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.